Edit |   |
---|---|
Antigenic Specificity | C5, Human (Ravulizumab biosimilar) |
Clone | Ravulizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG2-G4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human C5 Recombinant Antibody (Ravulizumab). Ravulizumab, sold under the brand name Ultomiris, is a humanized monoclonal antibody complement inhibitor medication designed for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome. It is designed to bind to and prevent the activation of Complement component 5 (C5). |
Immunogen | n/a |
Other Names | Anti-C5 Recombinant Antibody, Research Grade Ravulizumab, Anti-Human C5 Recombinant Antibody(Ravulizumab), ALXN-1210, ravulizumab-cwvz, Antibody Drug Analogues, Monoclonal Antibody, YR1443, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1803171-55-2 |
Catalog # | YR1443 |
Price | please inquire |
Order / More Info | C5, Human (Ravulizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |